Interestingly, EPH inhibition can be exploited to enhance the effectiveness of the currently applied treatment modalities, considering that EPHB1 knockdown in medulloblastoma cells has been shown to enhance cellular radiosensitization [106]. The gene discussed is EPHA1; the disease is medulloblastoma.